share_log

HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $3 Price Target

HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $3 Price Target

HC Wainwright & Co.重申买入 TransCode Therapeutics,维持3美元的目标股价
Benzinga ·  2023/10/25 00:03

HC Wainwright & Co. analyst Emily Bodnar reiterates TransCode Therapeutics (NASDAQ:RNAZ) with a Buy and maintains $3 price target.

HC Wainwright & Co. 分析师艾米丽·博德纳尔重申TransCode Therapeutics(纳斯达克股票代码:RNAZ)的买入并维持3美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发